AKT1 and cancer: The results revealed significant enrichment of multiple cancer-related signaling pathways, including the PI3K-Akt, MAPK, Ras, and JAK-STAT pathways, as well as the PD-L1 expression and PD-1 checkpoint pathway in cancer (Figure 7K).